BelHealth Investment Partners, LLC announced that it has completed the sale of Waltham, Massachusetts-based VFP Pharmacy Group. According to data captured in the LevinPro HC database, this transaction represents the 17th Specialty Pharmacy transaction of 2024. There were 15 Specialty Pharmacy transactions during 2023, and 27 announced during 2022.
VFP Pharmacy Group is one of the largest independent national fertility pharmacies in the United States. The company was created via the merger of four specialty pharmacies: Village Fertility Pharmacy in Boston, Village Fertility Pharmacy in Chicago, Integrity Rx Specialty Pharmacy in Phoenix and Integrity Rx Specialty Pharmacy in Los Angeles.
BelHealth Investment Partners is a healthcare private equity firm focused on lower-middle-market companies. The firm typically invests $20 million to $50 million per platform company across three healthcare segments: services, products and distribution.
BelHealth acquired VFP in August 2015, completed three add-on acquisitions and grew revenues more than five-fold primarily through organic growth by securing large institutional contracts with leading fertility payors and clinics.
Harold S. Blue, Founding Partner of BelHealth, said, “BelHealth identified an early opportunity to build a pre-eminent national fertility pharmacy to capitalize on favorable demographic and reimbursement trends in women’s health and I am proud of what the team accomplished.”
Truist Securities acted as exclusive advisor to VFP Pharmacy on the transaction. Financial terms of the deal were not disclosed.
